ESC 365 - Targeted theranostic microbubbles for the delivery of MicroRNA-126: diagnosis and localised treatment/prevention of abdominal aortic aneurysm

Open Access

Targeted theranostic microbubbles for the delivery of MicroRNA-126: diagnosis and localised treatment/prevention of abdominal aortic aneurysm

Session: Late Breaking Trial session

Topic: Gene Therapy, Cell Therapy

Speaker: Professor K. Peter (Melbourne, AU)

Event: Frontiers in CardioVascular Biology 2018

Congress Presentation

Add to my library

About the speaker

Professor Karlheinz Peter

Baker Heart and Diabetes Institute, Melbourne (Australia)

5 presentations

0 follower

5 more presentations in this session

IkB kinase 2 in atherosclerosis

Speaker: Doctor M. Mussbacher (Vienna, AT)

Direct effects of ponatinib on vascular endothelial cells: a potential explanation for development of vascular adverse events in CML patients

Speaker: Doctor E. Hadzijusufovic (Vienna, AT)

Electrically silent and stimulable iPSC-derived cardiomyocytes using RNA-guided epigenome editing

Speaker: Professor J. Hulot (Paris, FR)

A three-step approach to identify shear stress-sensitive endothelial microRNAs for the optimization of vasculoprotective exercise regimes

Speaker: Doctor B. Schmitz (Ennepetal, DE)

Potentiated beta-adrenergic effect on calcium handling in autophagy-defective mouse cardiomyocytes

Speaker: Associate Professor S. Sedej (Graz, AT)

Access the full session

Late Breaking Trial session

Speakers: Professor K. Peter, Doctor M. Mussbacher, Doctor E. Hadzijusufovic, Professor J. Hulot, Doctor B. Schmitz...

About the event

Frontiers in CardioVascular Biology 2018

20 April - 22 April 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources